Price Alert

KalVista Pharmaceuticals ... (KALV)

NASDAQ: KALV · Real-Time Price · USD

12.89

-0.06 (-0.46%)

At close: Aug 15, 2025, 3:59 PM

13.13

1.82%

After-hours: Aug 15, 2025, 07:39 PM EDT

KalVista Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Net Income	-183.44M	-126.64M	-92.91M	-82.34M	-46.24M
Depreciation & Amortization	955K	816K	718K	564K	537K
Stock-Based Compensation	n/a	21.91M	9.92M	11.09M	7.12M
Other Working Capital	23.63M	2.67M	6.31M	-14.01M	8.2M
Other Non-Cash Items	7.3M	-485K	84K	4.88M	114K
Deferred Income Tax	n/a	n/a	-491K	n/a	-42K
Change in Working Capital	22.28M	15.17M	7.41M	-12.32M	8.35M
Operating Cash Flow	-152.91M	-89.23M	-75.26M	-78.13M	-30.17M
Capital Expenditures	n/a	-443K	-1.2M	-931K	-82K
Cash Acquisitions	434K	n/a	-57.86M	-57.86M	147.65M
Purchase of Investments	30.57M	-189.23M	-98.25M	-136.92M	-201.21M
Sales Maturities Of Investments	122.52M	104.95M	140.86M	195.71M	53.64M
Other Investing Acitivies	-62.51M	-443K	57.86M	57.86M	-147.65M
Investing Cash Flow	91.02M	-84.72M	41.41M	57.86M	-147.65M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	98.04M	53.77M	1.53M	1.58M	1.53M
Financial Cash Flow	159.73M	150.71M	58.12M	1.58M	212.12M
Net Cash Flow	100.48M	-24.45M	25.51M	-19.86M	34.8M
Free Cash Flow	-152.91M	-89.67M	-76.46M	-79.06M	-30.25M